PetMed Express Company Profile (NASDAQ:PETS)

About PetMed Express

PetMed Express logoPetMed Express, Inc. (PetMed Express), doing business as 1800PetMeds, is a pet pharmacy. The Company markets prescription and non-prescription pet medications, and other health products for dogs and cats, direct to the consumer. It offers a selection of products for dogs and cats. Its product line contains approximately 3,000 stock keeping units (SKUS) of pet medications, health products and supplies. Its products include brands of medication, such as Frontline Plus, K9 Advantix II, Advantage II, Heartgard Plus, Sentinel, Revolution and Rimadyl. It also offers additional pet supplies for sale on its Website, which are drop shipped to its customers by third parties. These pet supplies include food, beds, crates, stairs, strollers and other pet supplies. Its products included Non-Prescription Medications (Over the Counter (OTC)) and supplies, and Prescription Medications (Rx). Its customers are located in California, Florida, Texas, New York, Virginia and Georgia, among others.

Industry, Sector and Symbol:
  • Sector: Retail/Wholesale
  • Industry: Drug Delivery
  • Sub-Industry: Internet Retail
  • Exchange: NASDAQ
  • Symbol: PETS
  • CUSIP: 71638210
Key Metrics:
  • Previous Close: $21.18
  • 50 Day Moving Average: $21.72
  • 200 Day Moving Average: $21.22
  • 52-Week Range: $16.47 - $23.78
  • Trailing P/E Ratio: 19.79
  • Foreward P/E Ratio: 18.91
  • P/E Growth: 4.40
  • Market Cap: $428.96M
  • Outstanding Shares: 20,253,000
  • Beta: 1.02
  • Net Margins: 9.00%
  • Return on Equity: 25.06%
  • Return on Assets: 22.63%
  • Current Ratio: 8.53%
  • Quick Ratio: 6.65%
Additional Links:
Companies Related to PetMed Express:

Analyst Ratings

Consensus Ratings for PetMed Express (NASDAQ:PETS) (?)
Ratings Breakdown: 1 Sell Rating, 1 Hold Rating
Consensus Rating:Hold (Score: 1.50)
Consensus Price Target: $13.00 (38.62% downside)

Analysts' Ratings History for PetMed Express (NASDAQ:PETS)
DateFirmActionRatingPrice TargetDetails
8/16/2016Credit Suisse GroupReiterated RatingSell$13.00View Rating Details
5/9/2016Craig HallumUpgradeSell -> HoldView Rating Details
5/5/2015Piper Jaffray CompaniesReiterated RatingReduce -> NeutralView Rating Details
(Data available from 2/24/2015 forward)


Earnings History for PetMed Express (NASDAQ:PETS)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
1/23/2017Q3 2017$0.25$0.24$52.70 million$52.90 millionViewN/AView Earnings Details
10/24/2016Q2$0.26$0.24$58.47 million$60.80 millionViewN/AView Earnings Details
7/25/2016Q1$0.31$0.32$72.50 millionViewN/AView Earnings Details
5/9/2016Q4$0.25$0.27$50.20 million$55.40 millionViewN/AView Earnings Details
1/25/2016Q316$0.25$0.24$49.28 million$50.90 millionViewListenView Earnings Details
10/19/2015Q216$0.20$0.22$58.34 million$56.70 millionViewListenView Earnings Details
7/20/2015Q116$0.28$0.29$73.04 million$71.60 millionViewN/AView Earnings Details
5/4/2015Q415$0.25$0.25$49.11 million$50.00 millionViewN/AView Earnings Details
1/20/2015Q315$0.24$0.24$49.26 million$49.30 millionViewN/AView Earnings Details
10/20/2014Q215$0.21$0.19$61.22 million$57.60 millionViewListenView Earnings Details
7/21/2014Q115$0.25$0.25$74.25 million$72.50 millionViewN/AView Earnings Details
5/5/2014Q414$0.22$0.23$55.02 million$48.60 millionViewN/AView Earnings Details
1/21/2014Q214$0.23$0.23$52.06 million$50.10 millionViewN/AView Earnings Details
10/21/2013Q213$0.22$0.20$60.33 million$80.50 millionViewN/AView Earnings Details
7/22/2013Q1 2013$0.22$0.24$69.55 million$74.20 millionViewN/AView Earnings Details
5/6/2013Q4 2012$0.21$0.23$55.31 million$51.10 millionViewN/AView Earnings Details
1/22/2013Q3 2012$0.17$0.23$49.97 million$49.60 millionViewN/AView Earnings Details
10/22/2012$0.17$0.20ViewN/AView Earnings Details
7/23/2012$0.23$0.20ViewN/AView Earnings Details
5/7/2012$0.18$0.20ViewN/AView Earnings Details
1/23/2012$0.16$0.19ViewN/AView Earnings Details
10/24/2011$0.15$0.19ViewN/AView Earnings Details
7/18/2011$0.24$0.22ViewN/AView Earnings Details
5/9/2011$0.23$0.19ViewN/AView Earnings Details
1/24/2011$0.20$0.20ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for PetMed Express (NASDAQ:PETS)
Current Year EPS Consensus Estimate: $1.06 EPS
Next Year EPS Consensus Estimate: $1.12 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161$0.24$0.24$0.24
Q2 20161$0.29$0.29$0.29
Q3 20161$0.23$0.23$0.23
Q4 20162$0.24$0.25$0.25
Q1 20172$0.30$0.30$0.30
Q2 20172$0.23$0.28$0.26
Q3 20172$0.23$0.26$0.25
Q4 20172$0.25$0.26$0.26
Q1 20181$0.33$0.33$0.33
Q2 20181$0.24$0.24$0.24
Q3 20181$0.24$0.24$0.24
Q4 20181$0.26$0.26$0.26
(Data provided by Zacks Investment Research)


Current Dividend Information for PetMed Express (NASDAQ:PETS)
Annual Dividend:$0.76
Dividend Yield:3.59%
Payout Ratio:71.03% (Based on Trailing 12 Months of Earnings)
71.70% (Based on Current Year Consensus EPS Estimate)
67.86% (Based on Next Year Consensus EPS Estimate)

Dividend History for PetMed Express (NASDAQ:PETS)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for PetMed Express (NASDAQ:PETS)
Insider Ownership Percentage: 4.70%
Institutional Ownership Percentage: 73.16%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
12/13/2016Menderes AkdagCEOSell10,000$23.00$230,000.00View SEC Filing  
12/9/2016Bruce S RosenbloomInsiderSell1,500$23.00$34,500.00View SEC Filing  
12/7/2016Menderes AkdagCEOSell3,107$22.75$70,684.25View SEC Filing  
11/25/2016Menderes AkdagCEOSell6,274$22.25$139,596.50View SEC Filing  
11/16/2016Frank J FormicaDirectorSell10,000$21.75$217,500.00View SEC Filing  
11/14/2016Bruce S RosenbloomInsiderSell3,000$21.75$65,250.00View SEC Filing  
11/14/2016Menderes AkdagCEOSell40,000$21.63$865,200.00View SEC Filing  
10/10/2016Bruce S RosenbloomInsiderSell1,500$21.00$31,500.00View SEC Filing  
10/10/2016Menderes AkdagCEOSell10,000$21.00$210,000.00View SEC Filing  
9/22/2016Menderes AkdagCEOSell10,000$20.75$207,500.00View SEC Filing  
8/12/2016Bruce S RosenbloomInsiderSell8,000$20.38$163,040.00View SEC Filing  
8/11/2016Robert C SchweitzerDirectorSell3,000$20.59$61,770.00View SEC Filing  
8/9/2016Robert C SchweitzerDirectorSell4,500$20.52$92,340.00View SEC Filing  
8/1/2016Ronald J KornDirectorSell4,000$20.76$83,040.00View SEC Filing  
5/9/2016Bruce S RosenbloomCFOSell5,500$19.54$107,470.00View SEC Filing  
3/30/2016Bruce S RosenbloomCFOSell1,500$18.00$27,000.00View SEC Filing  
3/14/2016Bruce S RosenbloomCFOSell3,000$17.25$51,750.00View SEC Filing  
2/22/2016Ronald J KornDirectorSell5,000$16.76$83,800.00View SEC Filing  
1/22/2016Bruce S RosenbloomCFOSell750$18.50$13,875.00View SEC Filing  
11/20/2015Ronald J KornDirectorSell1,000$17.01$17,010.00View SEC Filing  
7/14/2015Bruce S RosenbloomCFOSell400$18.25$7,300.00View SEC Filing  
7/13/2015Bruce S RosenbloomCFOSell100$18.25$1,825.00View SEC Filing  
6/19/2015Bruce S RosenbloomCFOSell1,000$17.88$17,880.00View SEC Filing  
6/19/2015Menderes AkdagCEOSell8,000$17.75$142,000.00View SEC Filing  
6/4/2015Menderes AkdagCEOSell9,930$17.50$173,775.00View SEC Filing  
5/8/2015Frank J FormicaDirectorSell7,500$16.51$123,825.00View SEC Filing  
4/23/2015Menderes AkdagCEOSell10,000$17.25$172,500.00View SEC Filing  
4/20/2015Menderes AkdagCEOSell10,000$17.00$170,000.00View SEC Filing  
4/13/2015Menderes AkdagCEOSell7,499$16.75$125,608.25View SEC Filing  
4/13/2015Ronald J KornDirectorSell2,000$16.75$33,500.00View SEC Filing  
4/8/2015Menderes AkdagCEOSell2,501$16.75$41,891.75View SEC Filing  
3/30/2015Menderes AkdagCEOSell10,000$16.50$165,000.00View SEC Filing  
3/25/2015Ronald J KornDirectorSell2,000$16.25$32,500.00View SEC Filing  
1/21/2015Menderes AkdagCEOSell60,000$15.63$937,800.00View SEC Filing  
1/20/2015Bruce S RosenbloomCFOSell2,167$15.40$33,371.80View SEC Filing  
8/15/2014Ronald J KornDirectorSell2,000$14.13$28,260.00View SEC Filing  
7/22/2014Bruce S RosenbloomCFOSell1,000$14.13$14,130.00View SEC Filing  
7/21/2014Bruce S RosenbloomCFOSell500$14.00$7,000.00View SEC Filing  
6/12/2014Bruce S RosenbloomCFOSell1,500$13.50$20,250.00View SEC Filing  
9/13/2013Menderes AkdagCEOSell10,000$17.00$170,000.00View SEC Filing  
9/11/2013Bruce S RosenbloomCFOSell6,666$16.21$108,055.86View SEC Filing  
8/14/2013Ronald KornDirectorSell1,000$16.25$16,250.00View SEC Filing  
8/12/2013Ronald KornDirectorSell1,000$16.18$16,180.00View SEC Filing  
7/31/2013Frank J FormicaDirectorSell7,000$16.39$114,730.00View SEC Filing  
7/22/2013Bruce S RosenbloomCFOSell6,250$16.74$104,625.00View SEC Filing  
3/6/2013Ronald J KornDirectorSell2,000$13.50$27,000.00View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for PetMed Express (NASDAQ:PETS)
News IconAnalysts Take Aim At This Stock's Earnings Estimates: PetMed Express, Inc. (NASDAQ:PETS) - Aiken Advocate (NASDAQ:PETS) - February 24 at 12:16 AM
News IconAnalysts Peer Into Their Crystal Balls For PetMed Express, Inc. (NASDAQ:PETS): Where Is It headed? - Winfield Review (NASDAQ:PETS) - February 20 at 6:27 PM
News IconWhere is PetMed Express, Inc. (NASDAQ:PETS) Headed Near Term? - Rockville Register (NASDAQ:PETS) - February 17 at 4:50 PM
News IconEarnings According to Analysts for PetMed Express, Inc. (NASDAQ:PETS)? - Aiken Advocate (NASDAQ:PETS) - February 17 at 4:50 PM
News IconLooking Closer at Shares of PetMed Express, Inc. (NASDAQ:PETS) - Benton Bulletin (NASDAQ:PETS) - February 10 at 8:09 PM logoPETMED EXPRESS INC Files SEC form 8-K, Other Events (NASDAQ:PETS) - February 8 at 8:09 PM logoPetMed Express, Inc. (NASDAQ:PETS) Files An 8-K Other Events ... - Market Exclusive (NASDAQ:PETS) - February 7 at 12:18 AM logoPETMED EXPRESS INC Financials (NASDAQ:PETS) - February 3 at 8:00 PM
News IconSignal Watch: Checking the Numbers for PetMed Express Inc. (PETS) - Market Point (NASDAQ:PETS) - January 30 at 7:50 PM
News IconShould income investors buy PetMed Express Inc (PETS) before its ex-dividend date? (NASDAQ:PETS) - January 29 at 8:53 AM
News IconEarnings Analysis & Update for PetMed Express, Inc. (NASDAQ:PETS)? - Aiken Advocate (NASDAQ:PETS) - January 27 at 5:41 AM
News IconInvestors are Watching Shares of PetMed Express, Inc. (NASDAQ ... - The Tribune (NASDAQ:PETS) - January 26 at 4:38 AM
News IconEarnings in Full Force, Analysts Take Aim at PetMed Express, Inc. (NASDAQ:PETS) - Wall Street Beacon (NASDAQ:PETS) - January 26 at 4:38 AM
News IconNotable Wednesday Option Activity: STMP, PETS, GPRE (NASDAQ:PETS) - January 25 at 11:37 PM logoPetMed Express, Inc. (NASDAQ:PETS) Files An 8-K Other Events (NASDAQ:PETS) - January 25 at 11:37 PM logoETFs with exposure to PetMed Express, Inc. : January 25, 2017 (NASDAQ:PETS) - January 25 at 11:36 PM logoPETMED EXPRESS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits (NASDAQ:PETS) - January 25 at 11:36 PM logoPetMed Express, Inc. :PETS-US: Earnings Analysis: Q3, 2017 By the Numbers : January 24, 2017 (NASDAQ:PETS) - January 24 at 7:56 PM
News IconMcDonald's, Petmed Net Decline; Halliburton Net Swing to Loss (NASDAQ:PETS) - January 24 at 12:31 AM logoPetmed Express : tops 3Q revenue forecasts (NASDAQ:PETS) - January 24 at 12:31 AM logoQ3 2016 Petmed Express Inc Earnings Release - 08:00 am ET (NASDAQ:PETS) - January 24 at 12:31 AM logo8:03 am PetMed Express misses by $0.01, reports revs in-line (NASDAQ:PETS) - January 24 at 12:31 AM logoEdited Transcript of PETS earnings conference call or presentation 23-Jan-17 1:30pm GMT (NASDAQ:PETS) - January 24 at 12:31 AM
News IconStock Backsliding Ahead of the Bell: PetMed Express, Inc. (NASDAQ:PETS) - Aiken Advocate (NASDAQ:PETS) - January 23 at 7:31 PM
News IconPriming The Pump: Stock Volatility Spotted in PetMed Express, Inc. (NASDAQ:PETS) - Wall Street Beacon (NASDAQ:PETS) - January 23 at 7:31 PM logoPetMed Express, Inc. – Value Analysis (NASDAQ:PETS) : January 23, 2017 (NASDAQ:PETS) - January 23 at 7:31 PM logoPre-Market Earnings Report for January 23, 2017 : MCD, HAL, BOH, CBU, EFSC, PETS, BMRC - Nasdaq (NASDAQ:PETS) - January 23 at 9:34 AM logoEarnings Reaction History: PetMed Express, Inc., 25.0% Follow-Through Indicator, 3.7% Sensitive - Nasdaq (NASDAQ:PETS) - January 23 at 9:34 AM logoPetMed tops 3Q revenue forecasts (NASDAQ:PETS) - January 23 at 9:34 AM
News IconConsensus Estimates on Earnings & Stock Price in Focus for PetMed Express, Inc. (NASDAQ:PETS) Shares - Aiken Advocate (NASDAQ:PETS) - January 22 at 6:56 PM logoPetMed Express, Inc. breached its 50 day moving average in a Bearish Manner : PETS-US : January 20, 2017 (NASDAQ:PETS) - January 20 at 8:01 PM
News IconLooking Ahead for PetMed Express, Inc. (NASDAQ:PETS); Are These Shares Ready to Go Higher? - Aiken Advocate (NASDAQ:PETS) - January 20 at 5:20 AM logoSales Anticipated Of PetMed Express, Inc. (NASDAQ:PETS) At $240.72 - Investor Newswire (NASDAQ:PETS) - January 18 at 7:47 PM logoForm 8-K PETMED EXPRESS INC For: Jan 17 - (NASDAQ:PETS) - January 18 at 7:47 PM logoPetMed Express D/B/A 1-800-PETMEDS to Announce Its Third Quarter Financial Results on January 23, 2017 - GlobeNewswire (press release) (NASDAQ:PETS) - January 18 at 8:37 AM logoPetMed Express D/B/A 1-800-PETMEDS to Announce Its Third ... - GlobeNewswire (press release) (NASDAQ:PETS) - January 17 at 11:08 AM logoPetMed Express D/B/A 1-800-PETMEDS to Announce Its Third Quarter Financial Results on January 23, 2017 (NASDAQ:PETS) - January 17 at 11:08 AM logoPetMed Express, Inc. (NASDAQ:PETS) Records An Impact Score Of 0 - Investor Newswire (NASDAQ:PETS) - January 13 at 12:50 AM logoPetMed Express, Inc. : PETS-US: Dividend Analysis : November 07th, 2016 (record date) : By the numbers : January 5, 2017 (NASDAQ:PETS) - January 5 at 11:57 PM
News IconFollow The Money Into These Consumer Sectors (NASDAQ:PETS) - January 3 at 11:49 PM
News IconTechnical Roundup on Shares of PetMed Express Inc. (PETS) - StockTalk Daily (NASDAQ:PETS) - December 22 at 1:02 AM
News IconValue Composite Score Update on PetMed Express, Inc. (NASDAQ:PETS) - Marion Business Daily (NASDAQ:PETS) - December 20 at 1:39 PM
News IconInvestor Monitor: Narrowing in on PetMed Express, Inc. (NASDAQ ... - Marion Business Daily (NASDAQ:PETS) - December 19 at 8:13 AM
News IconWhat The Charts Are Saying About PetMed Express, Inc. (NASDAQ:PETS) - The Business Journal (NASDAQ:PETS) - December 18 at 12:40 AM
News IconCompany Stock Watch: PetMed Express, Inc. (NASDAQ:PETS) - Business Daily Leader (NASDAQ:PETS) - December 18 at 12:40 AM
News IconCompany Stock Watch: PetMed Express, Inc. (NASDAQ:PETS) - OIB News (NASDAQ:PETS) - December 15 at 8:13 PM
News IconMF Rank Review for PetMed Express, Inc. (NASDAQ:PETS) - Liberty News (NASDAQ:PETS) - December 15 at 6:01 AM
News IconVC Score In Focus for PetMed Express, Inc. (NASDAQ:PETS) - Marion Business Daily (NASDAQ:PETS) - December 15 at 6:01 AM
News IconInvestor Hub: Looking at Shares of PetMed Express, Inc. (NASDAQ:PETS) - OIB News (NASDAQ:PETS) - December 13 at 7:34 PM logoIs Petmed Express Inc (PETS) Going to Burn Investors? (NASDAQ:PETS) - December 10 at 6:30 PM


What is PetMed Express' stock symbol?

PetMed Express trades on the NASDAQ under the ticker symbol "PETS."

How often does PetMed Express pay dividends? What is the dividend yield for PetMed Express?

PetMed Express declared a quarterly dividend on Monday, January 23rd. Investors of record on Monday, February 6th will be paid a dividend of $0.19 per share on Friday, February 17th. This represents a $0.76 annualized dividend and a dividend yield of 3.59%. The ex-dividend date is Thursday, February 2nd.

Where is PetMed Express' stock going? Where will PetMed Express' stock price be in 2017?

2 equities research analysts have issued 1 year price targets for PetMed Express' stock. Their predictions range from $13.00 to $13.00. On average, they anticipate PetMed Express' stock price to reach $13.00 in the next twelve months.

When will PetMed Express announce their earnings?

PetMed Express is scheduled to release their next quarterly earnings announcement on Monday, May, 8th 2017.

Who owns PetMed Express stock?

PetMed Express' stock is owned by a number of of retail and institutional investors. Top institutional investors include Renaissance Technologies LLC (7.89%), Dimensional Fund Advisors LP (3.16%), State Street Corp (3.11%), Royce & Associates LP (1.53%), Numeric Investors LLC (0.77%) and Allianz Asset Management AG (0.75%). Company insiders that own PetMed Express stock include Bruce S Rosenbloom, Frank J Formica, Menderes Akdag, Robert C Schweitzer and Ronald J Korn.

Who sold PetMed Express stock? Who is selling PetMed Express stock?

PetMed Express' stock was sold by a variety of institutional investors in the last quarter, including Royce & Associates LP, GSA Capital Partners LLP, Two Sigma Investments LP, AQR Capital Management LLC, Allianz Asset Management AG, O Shaughnessy Asset Management LLC, Metropolitan Life Insurance Co. NY and Paradigm Asset Management Co. LLC. Company insiders that have sold PetMed Express stock in the last year include Bruce S Rosenbloom, Frank J Formica, Menderes Akdag, Robert C Schweitzer and Ronald J Korn.

Who bought PetMed Express stock? Who is buying PetMed Express stock?

PetMed Express' stock was bought by a variety of institutional investors in the last quarter, including Dimensional Fund Advisors LP, Menta Capital LLC, Numeric Investors LLC, Russell Investments Group Ltd., State Street Corp, Renaissance Technologies LLC, Davy Asset Management Ltd and Summit Global Investments.

How do I buy PetMed Express stock?

Shares of PetMed Express can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of PetMed Express stock cost?

One share of PetMed Express stock can currently be purchased for approximately $21.18.

PetMed Express (NASDAQ:PETS) Chart for Friday, February, 24, 2017

Institutional Ownership Chart

Institutional Ownership by Quarter for PetMed Express (NASDAQ:PETS)

Earnings History Chart

Earnings by Quarter for PetMed Express (NASDAQ:PETS)

Dividend History Chart

Dividend Payments by Quarter for PetMed Express (NASDAQ:PETS)

Last Updated on 2/24/2017 by Staff